The Use of Non-Steroidal Anti-Inflammatory Drugs

This scientific brief describes a March 2020 rapid systematic review on NSAIDs and viral respiratory infections. At the time of the review, there was “no evidence of severe adverse events, acute health care utilization, long-term survival, or quality of life in patients with COVID-19” resulting from the use of NSAIDs.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.